American Renal Associates (ARA) Tops Q4 EPS by 3c

American Renal Associates (NYSE: ARA) reported Q4 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $194.4 million versus the consensus estimate of $195.32 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics